FDA approves Exforge and Diovan HCT

The US FDA has approved Diovan HCT (valsartan/hydrochlorothiazide) and Exforge (amlodipine/ valsartan), as first-line therapies in patients who need multiple drugs to achieve their blood pressure goals.

Exforge more effective than amlodipine alone

Exforge (valsartan/amlodipine) treatment results near twice as effective as amlodipine alone at reducing patients with high baseline blood pressure to a healthier blood pressure goal

Exforge treatment effective in black patients

Black patients treated with Exforge (Amlodipine/Valsartan) have been show to experience a significantly higher reduction in systolic blood pressure than those on amlodipine alone